Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.

Kuhen KL, Chatterjee AK, Rottmann M, Gagaring K, Borboa R, Buenviaje J, Chen Z, Francek C, Wu T, Nagle A, Barnes SW, Plouffe D, Lee MC, Fidock DA, Graumans W, van de Vegte-Bolmer M, van Gemert GJ, Wirjanata G, Sebayang B, Marfurt J, Russell B, Suwanarusk R, Price RN, Nosten F, Tungtaeng A, Gettayacamin M, Sattabongkot J, Taylor J, Walker JR, Tully D, Patra KP, Flannery EL, Vinetz JM, Renia L, Sauerwein RW, Winzeler EA, Glynne RJ, Diagana TT.

Antimicrob Agents Chemother. 2014 Sep;58(9):5060-7. doi: 10.1128/AAC.02727-13. Epub 2014 Jun 9.

2.

Effectiveness of a pharmacist-implemented anemia management protocol in an outpatient hemodialysis unit.

To LL, Stoner CP, Stolley SN, Buenviaje JD, Ziegler TW.

Am J Health Syst Pharm. 2001 Nov 1;58(21):2061-5. No abstract available.

PMID:
11715828

Supplemental Content

Loading ...
Support Center